REG - Fevertree Drinks PLC - Block Admission Application

Fevertree DrinksAnnouncement

23/05/2019 07:05

RNS Number : 9103Z
Fevertree Drinks PLC
23 May 2019
 


23 May 2019
 
Fevertree Drinks plc
 ("Fever-Tree" or the "Company")
 
Block Admission Application
 
The Company announces that a block admission application has been made to the London Stock Exchange for the admission of 660,194 ordinary shares of 0.25p each in connection with the Company's Long Term Incentive Plan.
 
The Shares will be issued credited as fully paid and will rank pari passu with the existing ordinary shares of the Company. Admission of the Shares is expected to take place on 24 May 2019.
 
Ends
 
For further information:
 



Fevertree Drinks plc


+44 (0)20 7349 4922




Tim Warrillow, Co-founder and CEO








Andy Branchflower, Finance Director








Oliver Winters, Communications & IR Director


















Numis Securities - Nominated Adviser and Joint Broker


+44 (0)20 7260 1000




Garry Levin








Matt Lewis








Hugo Rubinstein


















Investec Bank plc - Joint Broker


+44 (0)20 7597 5970




David Flin








Alex Wright








David Anderson


















Brunswick Group


+44 (0) 20 7404 5959




Jonathan Glass








Fiona Micallef-Eynaud








Cerith Evans







 
 
Notes to Editors:
 
Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSDMGZKVZMGLZM